A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention

PHASE2CompletedINTERVENTIONAL

Enrollment

400

Participants

Timeline

Start Date

March 25, 2022

Primary Completion Date

September 15, 2022

Study Completion Date

October 13, 2022

Conditions

COVID-19

Interventions

DRUG

Ivermectin Tablets

Daily ivermectin tablets intake for 28 days ; 200 mcg/kg on D1 then 100 mcg/kg daily from D2 to D28.

DRUG

Matching placebo tablets

Daily placebo tablets intake for 28 days

Trial Locations (1)

Medical Center Medic Ltd., Sofia